COLCRYS reduced gout flare pain in some patients in 1 day when taken at the first sign of a flare, AND its active ingredient (colchicine) helped prevent flares in patients starting on uric acid-lowering medications.
Gout is a chronic condition that affects approximately 8.3 million Americans, and it doesn't usually go away on its own—but it can be managed with a proper treatment plan.
Why take COLCRYS?
3 different ways to save on prescriptions*: COLCRYS Co-pay Assistance Program, a FREE 7-tablet voucher, and the COLCRYS Patient Assistance Program.
Save on COLCRYS *Must meet eligibility requirements.
Questions about gout and COLCRYS?Get help starting the conversation.
Are you aware of what could trigger gout flares?It's important to know.
COLCRYS (colchicine, USP) 0.6 mg tablet is a prescription medicine used in adults to prevent and treat gout flares.
COLCRYS is not a pain medicine and should not be taken to treat pain related to other conditions.
Individual results may vary.
For further information, please talk to your healthcare provider and see the complete Prescribing Information and Medication Guide for COLCRYS.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
COLCRYS is a trademark of Takeda Pharmaceuticals U.S.A., Inc., registered with the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.
©2013 Takeda Pharmaceuticals U.S.A., Inc.
This site is intended for U.S. residents only. EHC-00034 3/13